Oaktree Acquisition Corp. III Life Sciences (Nasdaq: OACC) is a blank-check company sponsored by Oaktree Capital Management, the Los Angeles-based alternative investment firm, with a stated focus on the life sciences sector. The vehicle represents the third SPAC raised under the Oaktree Acquisition Corp. banner, reflecting the sponsor's continued use of the blank-check structure for targeted sector investing. OACC filed a Form 10-Q with the SEC on May 14, 2025, indicating the company remains in its search period for a qualifying business combination. The filing covers routine quarterly disclosures while the sponsor continues to evaluate potential life sciences merger candidates. Sign up at SpacDesk for full filings, deal-status tracking, and analytics on OACC and every active SPAC in the market.